HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$14.21
Day range
$13.77 - $14.50
Year range
$8.69 - $24.13
Market cap
471.57M USD
Avg Volume
399.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 23.53M | 30.06% |
Operating expense | 35.85M | -0.71% |
Net income | -26.02M | 9.88% |
Net profit margin | -110.57 | 30.71% |
Earnings per share | -0.72 | 40.98% |
EBITDA | -14.42M | 28.07% |
Effective tax rate | -17.39% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 136.97M | 37.02% |
Total assets | 178.31M | 31.48% |
Total liabilities | 243.52M | 8.24% |
Total equity | -65.21M | — |
Shares outstanding | 34.12M | — |
Price to book | -7.07 | — |
Return on assets | -19.64% | — |
Return on capital | -78.20% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -26.02M | 9.88% |
Cash from operations | -13.00M | 40.25% |
Cash from investing | -11.34M | -149.09% |
Cash from financing | 40.00K | -99.84% |
Net change in cash | -24.30M | -190.93% |
Free cash flow | -409.88K | 95.71% |
About
Founded
2004
Headquarters
Website
Employees
198